Showing results (311-320 of 1,303) with videos related to
Sort By:
Pageof 131
Journal of Gynecologic Oncology|June 27, 2026
Understanding mortality trends in patients with uterine malignancies from 1999 to 2023 utilizing the CDC WONDER databaseShannon Blee, Sun Young Guwn, Olivia Foley, et al.Journal of Gynecologic Oncology|July 7, 2026
Performance of multi-parameter differential diagnostic models for ovarian cancer screening in women with adnexal massesNingtao Cheng, Mengyan Tu, Chenchun Zhang, et al.Journal of Gynecologic Oncology|July 7, 2026
Comparative performance of first-void urine and self-collected vaginal swabs against clinician-collected cervical samples using 2 HPV real-time assays in Indian womenRajeswari A, John Dickson Calvin Devadasan, Vinotha Thomas, et al.Journal of Gynecologic Oncology|August 7, 2026
Real-world safety and effectiveness of olaparib maintenance after first-relapse platinum-sensitive ovarian cancer in Japan: a multicenter historical cohort (JGOG3026)Kosuke Yoshihara, Terumi Tanigawa, Shin Nishio, et al.Journal of Gynecologic Oncology|August 7, 2026
Robotic versus conventional laparoscopic total hysterectomy in patients with endometrial cancer and frailty: analysis of the National Readmission Database, 2016-2020Huang-Pin Shen, Chih-Yu Chou, Hao-Jung Chang, et al.Journal of Gynecologic Oncology|August 7, 2026
cfDNA-inferred putative clonal hematopoiesis during first-line platinum-to-PARP inhibitor maintenance in ovarian cancerMika Okazawa-Sakai, Takao Fujisawa, Tatsuyuki Chiyoda, et al.Journal of Gynecologic Oncology|August 7, 2026
Burden and temporal trends of cervical cancer in reproductive-age females from 1990 to 2021 and projections to 2035 in G20 countries: a systematic analysis of the Global Burden of Disease Study 2021Xiangwen Li, Siyu Pan, Pengfei Qu, et al.Journal of Gynecologic Oncology|July 19, 2026
Camrelizumab combined with chemotherapy as postoperative adjuvant therapy after radical surgery for cervical cancer patients with pathologically positive lymph nodes: a prospective multicenter phase II clinical trialLiqing Chen, Tingting Chen, Nalan Tu, et al.Journal of Gynecologic Oncology|August 7, 2026
Limited prognostic impact of mismatch repair status in high-intermediate risk early-stage endometrial cancer receiving adjuvant radiotherapy: a retrospective cohort studySzu-Yu Huang, Hao Lin, Yu-Che Ou, et al.Journal of Gynecologic Oncology|August 21, 2026
Screening of potential antibody-drug conjugate (ADC) targets in neuroendocrine carcinoma of the cervix: implications for targeted therapyTianhui He, Xiaoxia Jiang, Jiangsha Li, et al.Pageof 131